100
Participants
Start Date
October 1, 2024
Primary Completion Date
July 1, 2026
Study Completion Date
July 1, 2026
Molecular Profiling & drug testing in tumor organoids and PDXs
Molecular profiling of native tumor will be performed and analyzed by using a self-designed panel. Tumor organoids will be cultured from fresh tumor tissues and patient-derived xenografts model will be established using the tumor organoids. Drugs will be tested in the two models. And the recommendation will be communicated to the clinicians.
Wuhan Union Hospital, China, Wuhan
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER